Skip to content
DE

Getting your heart checked: which tests help, and when?

Clinical review pending

ECGs, blood tests, ultrasound, and CT answer different heart-health questions. Learn which tests fit your symptoms or risk, and when to call emergency services.

A hand holds an open blank book with three colored windows.

The right heart test starts with a simple question: are you having symptoms now, or do you want to understand your future risk? Urgent warning signs call for immediate help. Prevention usually starts with a conversation, a blood pressure reading, and selected blood tests. An elaborate scan is not automatically the best first step.

Your primary care clinician can bring together your medical history, medications, family history, and symptoms. That helps establish whether an ECG, an ultrasound, or further cardiology testing would answer a useful question. The US National Heart, Lung, and Blood Institute offers an overview.

Two reasons to check your heart: symptoms and prevention

Chest pain, breathlessness, a racing heart, unusual exhaustion, or fainting call for an investigation into the cause and any immediate danger. The timing and pattern can matter as much as a single measurement. Does the pain start during exercise? Does your heart suddenly race? Does the breathlessness settle when you rest?

Testing people without symptoms has a different purpose: estimating their chances of future cardiovascular disease and planning effective prevention. Blood pressure, cholesterol, diabetes, smoking, and a family history of heart disease all contribute to that assessment.

The 2019 US primary prevention guideline considered it reasonable to assess traditional risk factors at least every 4–6 years in adults ages 20–39. It recommended calculating ten-year risk for adults ages 40–75. Since then, the 2026 US dyslipidemia guideline has introduced the PREVENT equations for assessing ten- and thirty-year risk to guide primary prevention lipid treatment in adults ages 30–79. These are US guideline frameworks. The checks available to you, their coverage, and the most suitable risk calculator depend on your country and circumstances. Existing conditions may call for much closer monitoring.

Heart attack warning signs: call emergency services first

Pressure, tightness, or pain in the chest can signal a heart attack, particularly if it is new, persistent, or accompanied by breathlessness, a cold sweat, nausea, or lightheadedness. Discomfort may spread to one or both arms, the back, shoulders, neck, jaw, or upper abdomen. Sudden unusual exhaustion or an irregular heartbeat can also occur. Not every heart attack causes severe chest pain. The NHLBI describes these different warning signs.

If you suspect a heart attack, call 911 in the United States, 112 in the European Union, or your local emergency number. Do not drive yourself to the hospital or wait for a private lab appointment or a smartwatch result. Emergency responders can begin assessment and treatment on the way.

A prompt ECG and blood tests for troponin are central to the emergency assessment. Troponin indicates injury to heart muscle cells; an elevated result alone does not prove that a heart attack has occurred. Symptoms, the ECG, and changes in troponin over time need to be considered together. Repeat testing may be needed, particularly early on. The NHLBI’s information on heart attack diagnosis, MedlinePlus, and a review of high-sensitivity troponin testing explain why.

Common heart tests and what they show

No single test answers every question. An ECG records electrical signals, ultrasound shows movement and structure, and CT can show the coronary arteries. Here is how the main approaches differ; the NHLBI explains their uses.

Test What it can show What happens
Resting ECG Heart rate, rhythm, and certain signs of impaired blood supply Electrodes on the skin record electrical activity; noninvasive.
Ambulatory ECG or event recorder Intermittent rhythm disturbances that a brief office ECG may miss A wearable device records your heart rhythm over a longer period during everyday life.
Echocardiogram Heart size, pumping function, valves, and other structural changes Ultrasound through the chest wall; noninvasive.
Stress test How the heart responds to exercise or medication-induced stress A treadmill or exercise bike, or medication when appropriate, sometimes combined with imaging.
Coronary artery calcium scan, or CAC score Calcified deposits in the coronary arteries CT without contrast dye, often taking about 10–15 minutes; involves radiation.
Coronary CT angiography The course of the coronary arteries, plaque, and possible narrowing CT with contrast dye injected into an arm vein; no arterial cardiac catheter.
Invasive coronary angiography Narrowed coronary arteries, with the option of further measurements or treatment A catheter is usually introduced through an artery at the wrist or groin; contrast dye and X-rays show the arteries.

A calcium score of zero means the scan detected no calcified deposits. Noncalcified plaque may still be present, so the result does not completely exclude coronary disease. Someone with symptoms should not rely on that finding alone for reassurance.

An abnormal noninvasive test may justify further investigation, but it does not automatically mean you need cardiac catheterization. Symptoms, the likelihood of a narrowing that needs treatment, and whether the result would change care all matter.

Blood markers that help explain cardiovascular risk

A lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides, among other values. It helps assess long-term risk and monitor treatment. These results do not tell you whether a heart attack is happening now. MedlinePlus explains the components of cholesterol testing.

Apolipoprotein B, or ApoB, can add information about the number of atherogenic lipoprotein particles. This can be useful when LDL cholesterol and other signs of metabolic risk do not seem to agree. ApoB does not count deposits in your arteries. A 2024 expert consensus describes its role in risk assessment.

Lipoprotein(a), or Lp(a), is largely genetically determined and can add to cardiovascular risk. The European Atherosclerosis Society’s 2022 consensus statement supports measuring it at least once in adulthood. An elevated result is a reason to discuss overall risk and the factors you can change.

High-sensitivity C-reactive protein, or hs-CRP, detects low concentrations of an inflammatory marker. It can contribute to risk assessment in selected situations, but many other conditions, including infections, can raise it. It does not exclusively measure inflammation in blood vessels or establish the stability of an individual plaque. A large analysis of CRP and disease risk describes the epidemiological association; that association does not make CRP a standalone diagnostic test for a specific narrowed artery.

Blood glucose and HbA1c help identify diabetes or impaired blood sugar regulation. HbA1c reflects approximately the preceding 2–3 months. Because diabetes raises cardiovascular risk, these measurements may be part of the assessment, depending on the circumstances. MedlinePlus explains the HbA1c test.

Which test fits your situation?

For recurring episodes of skipped beats or a racing heart, an ambulatory ECG is often more informative than a brief recording when symptoms happen only occasionally. Signs of valve disease or reduced pumping function may make an echocardiogram useful. With chest pain, the choice depends partly on how likely coronary disease is and whether the situation is acute. The 2021 chest pain guideline describes this risk-based approach.

An analysis of the diagnostic accuracy of coronary CT angiography reported a sensitivity of 94.6% for obstructive coronary disease, compared with 54.9% for exercise ECG. The analysis involved 2,920 people with stable chest pain and used at least 50% narrowing on invasive angiography as the reference definition. Sensitivity describes the proportion of people with the condition that a test detects. These numbers depend on the study population, the definition of important narrowing, and the reference test. They do not mean that everyone should start with CT.

What happens after testing matters, too. A meta-analysis comparing coronary CT angiography with functional stress testing found similar mortality rates and fewer heart attacks with the CT strategy, but more subsequent invasive coronary angiograms. Across the included trials, heart attacks occurred in 0.7% of the CT groups versus 1.1% of the functional-testing groups, over a mean follow-up of about 18 months. The choice therefore involves diagnostic accuracy, radiation exposure, contrast dye, possible incidental findings, and the expected benefit.

For people without symptoms, a coronary calcium scan can help in selected cases, such as when an estimated borderline or intermediate risk leaves uncertainty about preventive medication. It is not a compulsory routine check for every adult ages 40–75.

How to get started, step by step

  1. Book an appointment and explain your concern. Note your symptoms, when they started, possible triggers, medications, and any early heart disease in your family. Acute warning signs belong in emergency care immediately.
  2. Have your blood pressure assessed. Blood pressure measurement is a basic part of prevention. The US Preventive Services Task Force recommends screening from age 18; elevated office readings should generally be confirmed with appropriate measurements outside the office.
  3. Choose blood tests that answer a relevant question. A large package does not necessarily provide more useful information. Ask beforehand whether you need to fast and what to do about your usual medications.
  4. Discuss the results together. One result rarely provides the whole answer. What matters is whether it leads to a useful action, a follow-up measurement, or a referral.
  5. Check costs before elective additional testing. Medical indications, insurance coverage, and self-pay options differ, particularly for imaging and self-ordered lab tests.

Direct-to-consumer lab testing can make access easier, but it does not replace an examination when you have symptoms. Research on direct-to-consumer tests raises questions about interpretation and follow-up care. US laboratory rules such as 42 CFR 493.2 apply within a US regulatory framework; they do not establish the requirements for care in Germany or elsewhere.

At home, a validated blood pressure monitor and consistent technique can provide useful readings over time. A scientific statement on home blood pressure monitoring explains its value as a complement to care. A smartwatch can flag an irregular rhythm under certain conditions, but those notifications need medical confirmation. Both the large 2019 smartwatch study and a review of consumer ECG devices illustrate this distinction. A normal watch reading rules out neither a heart attack nor coronary disease.

Sources